The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular ...

Commissioner Marty Makary announced plans to roll-out a new approval pathway for rare disease drugs. Commissioner Makary’s comments build on sentiments expressed across both the patient community and ...

The Orphan Therapeutics Accelerator (OTXL), a non-profit biotech organization focused on completing development and ...

Bayer and Vividion Therapeutics to present latest research on their advancing oncology portfolio at AACR 2025 annual meeting: Berlin, Germany Wednesday, April 23, 2025, 10:00 Hrs ...

On Crowncast, Enrico Pesenti explains how cancer drug resistance forms and how advanced technologies are helping researchers ...

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...

In this In Focus, we explore how organ-on-a-chip technology is being used to improve drug discovery and development.

Osteoarthritis (OA) is one of the most prevalent conditions affecting tens of millions of U.S. adults, traditionally ...

Rare diseases, often referred to as orphan diseases, affect small patient populations, yet collectively they impact more than ...

The news has been welcomed by healthcare activists and patients as a significant development ... “Even with this possible cost cut, the drug will remain expensive and out of reach for a large ...

Inc.). “The collaboration underscores the transformative potential of our in silico technologies in drug development and exemplifies how digital tools can bridge the gap between preclinical ...